Vitreal IgM autoantibodies target neurofilament medium in a spontaneous model of autoimmune uveitis

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 1, 2012, Pages 294-300

  Swadzba, Margarete E ^a   Hirmer, Sieglinde ^a   Amann, Barbara ^a   Hauck, Stefanie M ^b   Deeg, Cornelia A ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NEUROFILAMENT M PROTEIN; AUTOANTIGEN; NEUROFILAMENT PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EQUINE RECURRENT UVEITIS; HORSE; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA GANGLION CELL; UVEITIS; VITREOUS BODY; WESTERN BLOTTING; ANIMAL; ANIMAL DISEASE; AUTOIMMUNE DISEASE; DISEASE MODEL; ENZYME IMMUNOASSAY; HORSE DISEASE; IMMUNOLOGY; RETINA; TWO DIMENSIONAL GEL ELECTROPHORESIS; VITRECTOMY;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HORSE DISEASES; HORSES; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN M; NEUROFILAMENT PROTEINS; RETINA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UVEITIS; VITRECTOMY; VITREOUS BODY;

EID: 84859221219     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8734     Document Type: Article

References (51)

1. Deeg CA, Hauck SM, Amann B, et al. Equine recurrent uveitis-a spontaneous horse model of uveitis. Ophthalmic Res. 2008;40: 151-153.
2. Caspi RR. A look at autoimmunity and inflammation in the eye. J Clin Invest. 2010;120:3073-3083.
3. Deeg CA, Raith AJ, Amann B, et al. CRALBP is a highly prevalent autoantigen for human autoimmune uveitis. Clin Dev Immunol. 2007;2007:39245.
4. Hauck SM, Schoeffmann S, Amann B, et al. Retinal Mueller glial cells trigger the hallmark inflammatory process in autoimmune uveitis. J Proteome Res. 2007;6:2121-2131.
5. Deeg CA, Thurau SR, Gerhards H, Ehrenhofer M, Wildner G, Kaspers B. Uveitis in horses induced by interphotoreceptor retinoid-binding protein is similar to the spontaneous disease. Eur J Immunol. 2002;32:2598-2606.
6. Deeg CA, Reese S, Gerhards H, Wildner G, Kaspers B. The uveitogenic potential of retinal S-antigen in horses. Invest Ophthalmol Vis Sci. 2004;45:2286-2292.
7. Deeg CA, Pompetzki D, Raith AJ, et al. Identification and functional validation of novel autoantigens in equine uveitis. Mol Cell Proteomics. 2006;5:1462-1470.
8. Hofmaier F, Hauck SM, Amann B, Degroote RL, Deeg CA. Changes in matrix metalloproteinase network in a spontaneous autoimmune uveitis model. Invest Ophthalmol Vis Sci. 2011;52:2314-2320.
9. Deeg CA, Ehrenhofer M, Thurau SR, Reese S, Wildner G, Kaspers B. Immunopathology of recurrent uveitis in spontaneously diseased horses. Exp Eye Res. 2002;75:127-133.
10. Deeg CA, Kaspers B, Gerhards H, Thurau SR, Wollanke B, Wildner G. Immune responses to retinal autoantigens and peptides in equine recurrent uveitis. Invest Ophthalmol Vis Sci. 2001;42:393-398.
11. DiLillo DJ, Horikawa M, Tedder TF. B-lymphocyte effector functions in health and disease. Immunol Res. 2011;49:281-292.
12. Schroeder HW Jr, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010;125:S41-S52.
13. Deeg CA, Amann B, Raith AJ, Kaspers B. Inter- and intramolecular epitope spreading in equine recurrent uveitis. Invest Ophthalmol Vis Sci. 2006;47:652-656.
14. Zipplies JK, Hauck SM, Schoeffmann S, et al. Kininogen in autoimmune uveitis: decrease in peripheral blood stream versus increase in target tissue. Invest Ophthalmol Vis Sci. 2010;51:375-382.
15. Ehrenhofer MC, Deeg CA, Reese S, Liebich HG, Stangassinger M, Kaspers B. Normal structure and age-related changes of the equine retina. Vet Ophthalmol. 2002;5:39-47.
16. Eberhardt C, Amann B, Feuchtinger A, Hauck SM, Deeg CA. Differential expression of inwardly rectifying K+ channels and aquaporins 4 and 5 in autoimmune uveitis indicates misbalance in Muller glial cell-dependent ion and water homeostasis. Glia. 2011; 59:697-707.
17. Packeisen J, Buerger H, Krech R, Boecker W. Tissue microarrays: a new approach for quality control in immunohistochemistry. J Clin Pathol. 2002;55:613-615.
18. Al-Chalabi A, Miller CC. Neurofilaments and neurological disease. Bioessays. 2003;25:346-355.
19. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci. 2005;233:183-198.
20. Ruiz-Ederra J, Garcia M, Hicks D, Vecino E. Comparative study of the three neurofilament subunits within pig and human retinal ganglion cells. Mol Vis. 2004;10:83-92.
21. Commodaro AG, Bueno V, Belfort R Jr, Rizzo LV. Autoimmune uveitis: the associated proinflammatory molecules and the search for immunoregulation. Autoimmun Rev. 2011;10:205-209.
22. Caspi RR. Understanding autoimmune uveitis through animal models: The Friedenwald Lecture. Invest Ophthalmol Vis Sci. 2011;52:1872-1879.
23. Snir O, Widhe M, Hermansson M, et al. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. Arthritis Rheum. 2010;62:44-52.
24. Deeg CA, Altmann F, Hauck SM, et al. Down-regulation of pigment epithelium-derived factor in uveitic lesion associates with focal vascular endothelial growth factor expression and breakdown of the blood-retinal barrier. Proteomics. 2007;7:1540-1548.
25. Bevan MJ. Understand memory, design better vaccines. Nat Immunol. 2011;12:463-465.
26. Cooper NR. The classical complement pathway: activation and regulation of the first complement component. Adv Immunol. 1985;37:151-216.
27. Manickam B, Jha P, Matta B, Liu J, Bora PS, Bora NS. Inhibition of complement alternative pathway suppresses experimental autoimmune anterior uveitis by modulating T cell responses. J Biol Chem. 2011;286:8472-8480.
28. Jha P, Bora PS, Bora NS. The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol. 2007;44:3901-3908.
29. Zipplies JK, Kirschfink M, Amann B, Hauck SM, Stangassinger M, Deeg CA. Complement factor B expression profile in a spontaneous uveitis model. Immunobiology. 2010;215:949-955.
30. Gutierrez C, McNally M, Canto-Soler MV. Cytoskeleton proteins previously considered exclusive to ganglion cells are transiently expressed by all retinal neuronal precursors. BMC Dev Biol. 2011; 11:46.
31. Peichl L, Gonzalez-Soriano J. Unexpected presence of neurofilaments in axon-bearing horizontal cells of the mammalian retina. J Neurosci. 1993;13:4091-4100.
32. Knabe W, Washausen S, Happel N, Kuhn HJ. Development of starburst cholinergic amacrine cells in the retina of Tupaia belangeri. J Comp Neurol. 2007;502:584-597.
33. Balaratnasingam C, Morgan WH, Bass L, Kang M, Cringle SJ, Yu DY. Time-dependent effects of focal retinal ischemia on axonal cytoskeleton proteins. Invest Ophthalmol Vis Sci. 2010;51:3019-3028.
34. Balaratnasingam C, Morgan WH, Bass L, Matich G, Cringle SJ, Yu DY. Axonal transport and cytoskeletal changes in the laminar regions after elevated intraocular pressure. Invest Ophthalmol Vis Sci. 2007;48:3632-3644.
35. Balaratnasingam C, Morgan WH, Bass L, Cringle SJ, Yu DY. Timedependent effects of elevated intraocular pressure on optic nerve head axonal transport and cytoskeleton proteins. Invest Ophthalmol Vis Sci. 2008;49:986-999.
36. Huang X, Kong W, Zhou Y, Gregori G. Distortion of axonal cytoskeleton: an early sign of glaucomatous damage. Invest Ophthalmol Vis Sci. 2011;52:2879-2888.
37. Pease ME, McKinnon SJ, Quigley HA, Kerrigan-Baumrind LA, Zack DJ. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci. 2000;41:764-774.
38. Petzold A, Junemann A, Rejdak K, et al. A novel biomarker for retinal degeneration: vitreous body neurofilament proteins. J Neural Transm. 2009;116:1601-1606.
39. Mond JJ, Lees A, Snapper CM. T cell-independent antigens type 2. Annu Rev Immunol. 1995;13:655-692.
40. Vos Q, Lees A, Wu ZQ, Snapper CM, Mond JJ. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev. 2000;176:154-170.
41. Perrot R, Berges R, Bocquet A, Eyer J. Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration. Mol Neurobiol. 2008;38:27-65.
42. Yuan A, Rao MV, Sasaki T, et al. Alpha-internexin is structurally and functionally associated with the neurofilament triplet proteins in the mature CNS. J Neurosci. 2006;26:10006-10019.
43. Deng Y, Li B, Liu F, et al. Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease. FASEB J. 2008;22:138-145.
44. Barry DM, Carpenter C, Yager C, et al. Variation of the neurofilament medium KSP repeat sub-domain across mammalian species: implications for altering axonal structure. J Exp Biol. 2010;213: 128-136.
45. Yano T, Yamada K, Kimura A, et al. Autoimmunity against neurofilament protein and its possible association with HLA-DRB1*1502 allele in glaucoma. Immunol Lett. 2005;100:164-169.
46. Zhang Y, Li X, Qiao J. Neurofilament protein light in multiple sclerosis (in Chinese). Zhonghua Yi Xue Za Zhi. 2007;87:2745-2749.
47. Bartos A, Fialova L, Soukupova J, Kukal J, Malbohan I, Pitha J. Antibodies against light neurofilaments in multiple sclerosis patients. Acta Neurol Scand. 2007;116:100-107.
48. Salih AM, Nixon NB, Dawes PT, Mattey DL. Prevalence of antibodies to neurofilament polypeptides in patients with rheumatoid arthritis complicated by peripheral neuropathy. Clin Exp Rheumatol. 1998;16:689-694.
49. Karlsson JE, Rosengren LE, Haglid KG. Polyclonal antisera to the individual neurofilament triplet proteins: a characterization using ELISA and immunoblotting. J Neurochem. 1989;53:759-765.
50. Taylor AW, Kaplan HJ. Ocular immune privilege in the year 2010: ocular immune privilege and uveitis. Ocul Immunol Inflamm. 2010;18:488-492.
51. Nuti F, Peroni E, Real-Fernandez F, et al. Posttranslationally modified peptides efficiently mimicking neoantigens: a challenge for theragnostics of autoimmune diseases. Biopolymers. 2010;94: 791-799.